NIH-funded research NIH-funded research

Mitochondria and metabolism after burn injury

Official title: The Role of the Mitochondrion in the Metabolic Stress Response to Burn Trauma

Funded at Arkansas Children's Hospital Res Inst · NIH-11376347 · Data updated 2026-11-12

Researchers are exploring how tiny energy centers in cells called mitochondria change metabolism after severe burns to help people recover faster.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionArkansas Children's Hospital Res Inst
NIH-funded
Lab location1 site (Little Rock, United States)
Project startSeptember 1, 2021
Project endJune 30, 2026
Funding year2025
Award (this year)$70,715
NIH project number3R35GM142744-05S1
Project IDNIH-11376347 on NIH RePORTER

Who could benefit from this research

Could help

People who have experienced moderate to severe burn injuries and are in recovery or follow-up care would be most relevant for related future clinical studies.

Less likely to help

Those with only minor burns or with health issues unrelated to burn-induced metabolic changes are unlikely to see direct benefits from this laboratory-focused work in the near term.

What this research studies

This program uses new rodent models to trace how fat and muscle tissues are broken down, redistributed, and burned for energy after a burn injury. Scientists will label adipose and skeletal muscle to follow specific molecules and measure mitochondrial bioenergetics, reactive oxygen production, and mitochondrial DNA release. The work aims to link these mitochondrial changes to hypermetabolism, insulin resistance, altered lipid handling, and muscle wasting that patients often face after burns. Findings could point to cellular processes to target with future therapies to reduce complications and speed recovery.

Why it matters

Potential benefit: If successful, this work could identify new ways to lessen prolonged metabolic problems, muscle loss, and slow recovery after serious burns.

How similar studies have gone: Previous research has suggested mitochondria contribute to burn hypermetabolism, but the use of isotopically labeled tissues and detailed turnover tracing in these new models is a novel approach.

Where this research is happening

  • Arkansas Children's Hospital Res Inst
    Little Rock, United States
    Active

Researchers

  • Principal investigator: Porter, Craig — Arkansas Children's Hospital Res Inst
  • Study coordinator: Porter, Craig

Related research

Other NIH-funded projects on the same topics.

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

  • Shorter antifungal course for kids with candidemia

    A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606502

  • Shortened antifungal treatment for kids with candidemia

    A pediatric multicenter trial will test whether stopping antifungal therapy after 7 more days, following an initial 7 days of treatment, isas safe as continuing for 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606491

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.